Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Dermatol Venereol ; 129(2): 203-5, 2002 Feb.
Article in French | MEDLINE | ID: mdl-11937958

ABSTRACT

INTRODUCTION: Celecoxib (Celebrex(R)) is a new generation non-steroidal anti-inflammatory drug, recently introduced in France. We report a maculopapular rash due to this drug with positive patch-tests. CASE REPORT: A forty year-old man received with 3 tablets/day of celecoxib for intercostal pain. Nine days after initiation of treatment a maculopapular rash appeared. At the end of treatment, the eruption persisted for two days, then rapidly improved within one week. Six weeks later, patch-tests with celecoxib diluted at 20 p. 100 in petrolatum were positive at 48 hours. DISCUSSION: Cutaneous reactions due to celecoxib are rare. In our case report, the delay, clinical aspect, improvement on withdrawal of treatment and positive patch test all emphasize the imputability of celecoxib. We wish to underline the possible cutaneous reactions with this new non-steroidal anti-inflammatory drug.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Drug Eruptions/etiology , Sulfonamides/adverse effects , Adult , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Celecoxib , Drug Eruptions/diagnosis , Humans , Male , Pyrazoles , Skin Tests , Sulfonamides/administration & dosage , Tablets , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...